Gene · 571
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NFE2L3 drives hepatocellular carcinoma cell proliferation by regulating the proteasome-dependent degradation of ISGylated p53. | Cancer Sci | 2023 | 37350063 | PubTator, text mining | PubMed |
| 5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy. | Sci Rep | 2023 | 37349515 | PubTator, text mining | PubMed |
| Regulatory Mechanism of M1/M2 Macrophage Polarization in the Development of Autoimmune Diseases. | Mediators Inflamm | 2023 | 37332618 | PubTator, text mining | PubMed |
| Cytokine storm in individuals with severe COVID-19 decreases endothelial cell antioxidant defense via downregulation of the Nrf2 transcriptional factor. | Am J Physiol Heart Circ Physiol | 2023 | 37327001 | PubTator, text mining | PubMed |
| Vascular protection afforded by zinc supplementation in human coronary artery smooth muscle cells mediated by NRF2 signaling under hypoxia/reoxygenation. | Redox Biol | 2023 | 37315344 | PubTator, text mining | PubMed |
| BACH1 promotes lung adenocarcinoma cell metastasis through transcriptional activation of ITGA2. | Cancer Sci | 2023 | 37311571 | PubTator, text mining | PubMed |
| Oxidative Stress in Melanoma: Beneficial Antioxidant and Pro-Oxidant Therapeutic Strategies. | Cancers (Basel) | 2023 | 37297001 | PubTator, text mining | PubMed |
| Modulation of NRF2/KEAP1 Signaling in Preeclampsia. | Cells | 2023 | 37296665 | PubTator, text mining | PubMed |
| Pemetrexed induces ROS generation and cellular senescence by attenuating TS-mediated thymidylate metabolism to reverse gefitinib resistance in NSCLC. | J Cell Mol Med | 2023 | 37278440 | PubTator, text mining | PubMed |
| Carbon Dots for the Treatment of Inflammatory Diseases: An Appraisal of In Vitro and In Vivo Studies. | Oxid Med Cell Longev | 2023 | 37273553 | PubTator, text mining | PubMed |
| [Gene regulatory networks operated by iron-heme metabolism: focusing on the erythroid differentiation system]. | Rinsho Ketsueki | 2023 | 37271532 | PubTator, text mining | PubMed |
| Loss of the mitochondrial protein Abcb10 results in altered arginine metabolism in MEL and K562 cells and nutrient stress signaling through ATF4. | J Biol Chem | 2023 | 37269954 | PubTator, text mining | PubMed |
| Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer's disease. | Nat Neurosci | 2023 | 37264161 | PubTator, text mining | PubMed |
| Mitophagy in atherosclerosis: from mechanism to therapy. | Front Immunol | 2023 | 37261351 | PubTator, text mining | PubMed |
| PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response. | Front Oncol | 2023 | 37260977 | PubTator, text mining | PubMed |
| WWOX binds MERIT40 and modulates its function in homologous recombination, implications in breast cancer. | Cancer Gene Ther | 2023 | 37248434 | PubTator, text mining | PubMed |
| Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma. | Biomedicines | 2023 | 37239002 | PubTator, text mining | PubMed |
| Heme: The Lord of the Iron Ring. | Antioxidants (Basel) | 2023 | 37237940 | PubTator, text mining | PubMed |
| Single Nucleotide Polymorphisms' Causal Structure Robustness within Coronary Artery Disease Patients. | Biology (Basel) | 2023 | 37237520 | PubTator, text mining | PubMed |
| Nonmonotone invasion landscape by noise-aware control of metastasis activator levels. | Nat Chem Biol | 2023 | 37231268 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/571/papers?page=21